Injective is receiving more traction as Canary Capital makes progress in its filing for the Staked INJ ETF with the Securities and Exchange Commission of the United States. The proposed offering will be based on holding spot INJ and adding a staking component for institutional players in the United States.
In the meantime, Injective is seeing tremendous gains in network activity. These developments are strengthening the project’s institutional narrative while keeping its market structure firmly in focus.
Canary Capital Advances Staked INJ ETF Filing
As per the information made available by Injective, Canary Capital has filed Amendment No. 3 in their S-1 form for a Staked INJ ETF. This proposed product will have spot INJ and staking of not less than 90% of their institutional holdings within the U.S. This amendment is yet another example of the increasing institutional attention towards Injective.
Source: Injective’s X Post
This could also prove to be an additional step towards making the possible launch of such a project, even if the decision is still subject to regulations. A spot-based product with staking exposure would allow conventional investors to invest in INJ through regulation while having the staking aspect of the network integrated into the investment.
Injective Surpasses 3 Billion Network Transactions
This move by the ETF comes after the achievement of a huge milestone by the underlying network of Injective. According to Injective, it has achieved an impressive transaction volume of 3 billion in total. Within the last 30 days, it has recorded over 42 million transactions.
Source: Injective’s X Post
Transaction milestones add another layer of information to the narrative that Injective is creating around itself. Instead of being based just on financial product-related news, the network is also reporting increased on-chain activity.
An increased number of transactions can serve as a valuable metric for measuring adoption going forward.
Also Read: Injective Price Gains Momentum as On-Chain Activity Supports INJ Outlook
INJ Price Approaches Key $9 Resistance
INJ is headed towards a very technical area at the $9 mark. According to Crypto With Gopal, there is a possibility of a double bottom pattern developing on the charts with two significant lows occurring near the $2.70 mark. At this point, $9 becomes the neckline resistance level for the formation.
Source: Crypto With Gopal’s X Post
Breaking above the neckline would represent technical validation of the pattern, whereas failing near the level could help INJ continue trading in its wider range. In that regard, the $9 level is very significant when it comes to gauging the validation of the developing pattern.
INJ Price Setup Points to a Rally Toward $16
Crypto With Gopal pointed out the double-bottom pattern that might exist in INJ along with the likely price target of $16 in case of the breakout above the neckline level. The double-bottom formation is conditional upon the price staying above the $9 level.
This analysis brings an additional technical aspect to the overall fundamental aspects regarding Injective. However, the target that is estimated is nothing more than a prediction about the future performance of the market. The price will need to create a breakout above the neckline for the pattern to be completely validated.
What Happens Next for Injective?
As the recently filed amendment from Canary Capital continues through its regulatory processes, the planned launch of the Staked INJ ETF will remain one of the key factors that need to be kept track of, as future filings may affect the INJ narrative.
Additionally, Injective’s transactional numbers offer another figure to follow. It might be able to indicate whether the current milestone is the result of real growth. From a technical point of view, the level of $9 is still the most important, and the double bottom pattern is still dependent on its confirmation.
INJ is approaching a stage whereby there will be a convergence between institutional and network factors in addition to a technical formation.
This is after Canary Capital’s amendment on the Staked INJ ETF that boosts the institutional story and over 3 billion transactions that boost the technical story for Injective’s growth in on-chain activity. The $9 neckline remains a significant technical support level.
Also Read: Injective Signals New Development as INJ Price Gains Market Attention
This article contains market analysis and price predictions. These are not guarantees. Crypto markets are volatile. Always DYOR. Not financial advice.
Be the first to comment